Anti-Tyrosinase (TYR) CAR-T Preclinical in vivo Assay
TypeName: Business Offer
Category:
Offer Date:2019/06/24
Country: United States
Summary: Creative Biolabs provides GLP-compliant in vivo test services for anti-Tyrosinase (TYR) CAR-T cell therapy in melanoma. Melanoma antigen tyrosinase (TYR) is a single membrane-spanning transmembrane glycoprotein with 13% carbohydrate content and possesses tyrosine hydroxylase, and dopa oxidase catalytic activities.